Bolasterone is an oral AAS that was developed in the 1960s by the pharmaceutical company Wyeth. It was initially used in the treatment of cachexia, a condition characterized by severe weight loss and muscle wasting in patients with advanced cancer or other chronic illnesses. Unfortunately, it was abandoned because it was too powerful to be […]Read More